Literature DB >> 1583904

Long-term follow-up of behavioral self-control training.

W R Miller1, A L Leckman, H D Delaney, M Tinkcom.   

Abstract

Four samples of problem drinkers treated by behavioral self-control training were evaluated at 3.5, 5, 7 and 8 years following treatment, respectively. Of 140 cases, 99 (71%) were accounted for: 23 abstinent, 14 with controlled and asymptomatic drinking, 22 improved but still impaired, 35 unremitted and 5 deceased. Abstinent versus controlled-drinking outcomes were most strongly differentiated by pretreatment severity of alcohol problems and dependence and by the patients' pretreatment self-assessment and goals. Percentages of abstainers and of relapsed cases increased at long-term follow-ups. A reasonably constant percentage of known outcomes (14%) were clearly controlled and asymptomatic drinkers in each of the follow-up samples. Most of the long-term controlled drinkers had established this pattern within the first year following treatment. However, periods of controlled drinking during the first year did not reliably predict maintenance of this pattern. Successful asymptomatic drinkers were discriminable from other outcomes based on pretreatment characteristics.

Entities:  

Mesh:

Year:  1992        PMID: 1583904     DOI: 10.15288/jsa.1992.53.249

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  21 in total

1.  Problem-free drinking over 16 years among individuals with alcohol use disorders.

Authors:  Mark A Ilgen; Paula L Wilbourne; Bernice S Moos; Rudolf H Moos
Journal:  Drug Alcohol Depend       Date:  2007-08-23       Impact factor: 4.492

2.  A preliminary investigation of abstinence and controlled gambling as self-selected goals of treatment for female pathological gambling.

Authors:  Nicki Dowling; David Smith; Trang Thomas
Journal:  J Gambl Stud       Date:  2009-02-07

3.  Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers.

Authors:  A I Wilk; N M Jensen; T C Havighurst
Journal:  J Gen Intern Med       Date:  1997-05       Impact factor: 5.128

4.  Drink goal difficulty effect on outcomes in moderation-based alcohol treatment for sexual minority men.

Authors:  Svetlana Levak; Alexis N Kuerbis; Jon Morgenstern
Journal:  J Subst Abuse Treat       Date:  2020-01-09

Review 5.  Compulsive features in behavioural addictions: the case of pathological gambling.

Authors:  Nady el-Guebaly; Tanya Mudry; Joseph Zohar; Hermano Tavares; Marc N Potenza
Journal:  Addiction       Date:  2011-10-10       Impact factor: 6.526

Review 6.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

7.  Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials.

Authors:  Katie Witkiewitz; Matthew R Pearson; Kevin A Hallgren; Stephen A Maisto; Corey R Roos; Megan Kirouac; Adam D Wilson; Kevin S Montes; Nick Heather
Journal:  Addiction       Date:  2017-06-26       Impact factor: 6.526

8.  Engagement and retention in outpatient alcoholism treatment for women.

Authors:  Fiona S Graff; Thomas J Morgan; Elizabeth E Epstein; Barbara S McCrady; Sharon M Cook; Noelle K Jensen; Shalonda Kelly
Journal:  Am J Addict       Date:  2009 Jul-Aug

Review 9.  Candidates for liver transplantation with alcoholic liver disease: Psychosocial aspects.

Authors:  Diogo Telles-Correia; Inês Mega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

10.  Factors mediating the association between drinking in the first year after alcohol treatment and drinking at three years.

Authors:  Stephen A Maisto; Patrick R Clifford; Robert L Stout; Christine M Davis
Journal:  J Stud Alcohol Drugs       Date:  2008-09       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.